Sunnybrook Health Sciences Centre is the first hospital in North America to install Bayer's next generation MEDRAD® Centargo CT Injection System, designed for optimizing workflow
Health Canada approves KERENDIA® (finerenone) as an adjunct to standard of care therapy in adults with chronic kidney disease (CKD) and type 2 diabetes (T2D)
We research, develop and market innovative products that improve the health of people and plants. Our business comprises three core divisions and one business unit. Learn more about it here.